Kimberly Blackwell
金伯利·布莱克韦尔
MD
Professor of Medicine医学教授
👥Biography 个人简介
Kimberly Blackwell conducted pivotal research on neratinib in HER2+ breast cancer and led the ExteNET trial demonstrating extended adjuvant neratinib benefit. Her research on CNS metastases management in HER2+ breast cancer has informed treatment strategies for this challenging clinical scenario.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Extended Adjuvant HER2 Therapy
Led ExteNET trial demonstrating that extended adjuvant neratinib after trastuzumab reduced invasive disease-free survival events in HER2+ breast cancer.
CNS Metastases in HER2+ Breast Cancer
Contributed to understanding and managing brain metastases in HER2+ breast cancer, including studies of neratinib and capecitabine in CNS disease.
Representative Works 代表性著作
Randomized study of neratinib in combination with temsirolimus or trastuzumab in patients with HER2-positive metastatic breast cancer
Journal of Clinical Oncology (2012)
Early neratinib combination study.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-02-01 | All information from publicly available academic sources
Related Experts 相关专家
Hope S. Rugo
University of California, San Francisco (UCSF)
Maryam B. Lustberg
Yale School of Medicine / Yale Cancer Center
Sara M. Tolaney
Dana-Farber Cancer Institute / Harvard Medical School
Carlos H. Barrios
PUCRS (Pontifical Catholic University of Rio Grande do Sul) / Hospital São Lucas, Porto Alegre, Brazil
关注 金伯利·布莱克韦尔 的研究动态
Follow Kimberly Blackwell's research updates
留下邮箱，当我们发布与 Kimberly Blackwell（Duke Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment